AllPennyStocks.com TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial

TEM stock rose as investors connected the upbeat clinical results to Tempus’s planned $1.5 billion acquisition of Personalis, announced last month.

Other Penny Stock Movers

A $1 Billion Crypto Deal Sends This Microcap Surging
This Microcap Just Pulled Core From One of Copper's Last Frontiers
Target Expansion and Geophysics Survey Trigger 18% Surge for Norwegian Base-Metal Project


Back to Top